Michael Abrams, MA
Co-founder of Numerof & Associates
Articles
How a Congressional Defeat Could Translate into a Win for Patients
October 4th 2021Medicare negotiation of drug prices would stifle the development of much-needed therapies. Curtailing defensive medicine and rolling back excessive regulation would be a better way to control healthcare costs.
Read More
Latest Updated Articles
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: June 25th 2025 | Updated: July 3rd 2025
Diagnosing Type 1 Diabetes: Clinical Challenges and Consequences
Published: June 27th 2025 | Updated: July 3rd 2025
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
